Chiropractors in Red Oak, TX Accepting Medicare

10 Chiropractors found. Showing 1 - 10

Quicktime Fitness Chiropractor - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2506 Ovilla Road, Suite B, Red Oak, TX 75154 Phone: 469-245-9558

Dr. Daniel H Diaz, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 806 Rachelle Dr, Red Oak, TX 75154 Phone: 214-325-5101

Jason Scott Phillips, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 307 E Ovilla Rd Ste 100, Red Oak, TX 75154 Phone: 972-576-5501    Fax: 972-576-5654

Red Oak Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 307 E Ovilla Rd, Suite 100, Red Oak, TX 75154 Phone: 972-576-5501    Fax: 972-576-5654

Alysha Amayreh, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 109 E Ovilla Rd, Red Oak, TX 75154 Phone: 972-617-7700

Bradley Edward Brown Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 527 N State Highway 342, Red Oak, TX 75154 Phone: 972-617-8830    Fax: 972-617-0006

Dr. John Bryan Sappington, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 106 Sierra Grande, Suite 100, Red Oak, TX 75154 Phone: 972-617-5600    Fax: 972-617-5485

Brenda Basken Ross, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 307 E Ovilla Rd, Suite 100, Red Oak, TX 75154 Phone: 972-576-5501    Fax: 972-576-5654

Funomenal Fitness Chiropractor - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2506 Ovilla Rd Ste B, Red Oak, TX 75154 Phone: 469-245-9558

Rati M Patel, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 307 E Ovilla Rd Ste 100, Red Oak, TX 75154 Phone: 972-576-5501

News Archive

Natural compound slows typical signs of aging in mice

Much of human health hinges on how well the body manufactures and uses energy. For reasons that remain unclear, cells' ability to produce energy declines with age, prompting scientists to suspect that the steady loss of efficiency in the body's energy supply chain is a key driver of the aging process.

Sedative propofol could be fatal

Patients treated for their prolonged seizures with the sedative propofol may be at high risk for complications and even death. New research presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians (ACCP), shows that the use of propofol as an antiepileptic agent in patients with refractory status epilepticus (RSE), prolonged seizures that do not respond to initial treatment, was associated with significant mortality and morbidity.

Alnylam announces clinical data from patisiran Phase 2 OLE study for treatment of patients with FAP

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today initial 12-month clinical data from its ongoing Phase 2 open-label extension (OLE) study with patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis) in patients with familial amyloidotic polyneuropathy (FAP).

Public Health Advisory for medical professionals with patients on anti-depression medication

On Monday, March 22, 2004 the Food and Drug Administration issued a Public Health Advisory for medical professionals to monitor for signs of suicidal ideation in individuals who have recently started taking anti-depression medication or have had a recent change in dosage, especially for children who are taking these medications. Antidepressant medications involved in this warning include: Prozac (Fluoxetine), Zoloft, Paxil, Luvox, Celexa, Lexapro, Wellbutrin, Effexor,, Serzone, and Remeron.

Read more Medical News

› Verified 9 days ago